Vir Biotech Catapults On Its $1.71 Billion Deal With Astellas - Investor's Business Daily
business 2026/02/24 21:09:00

Vir Biotech Catapults On Its $1.71 Billion Deal With Astellas - Investor's Business Daily

Source:Investor's Business Daily
Author:None

Vir posted strong results for a prostate cancer treatment and crushed fourth-quarter views.